Kurashiki Central Hospital

Okayama 7108602

2 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Bleeding, Follicular Lymphoma, Idiopathic Pulmonary Fibrosis, Large B-cell Lymphoma, Myocardial Infarction, Non-Small-Cell Lung, RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors, Stroke

Studies at this site

• Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) — Completed
• Cryo Global Registry — Completed
• A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome — Completed
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early